Featured essay
AI adoption drives 65% of outsourced pharma R&D spending in 2026Modern Catalyst The pharmaceutical outsourcing landscape is undergoing a fundamental shift driven by AI and digital clinical infrastructure. Clinical development services represent 65–70% of outsourced pharma R&D spending, with AI adoption emerging as the primary lever for cost…
Read full essay